HISAMITSU PHARMACEUTICAL CO.,INC., First Half Ordinary Profit Decreases by 7%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Oct 10, 2024 3:00 pm JST Earnings

4530 HISAMITSU PHARMACEUTICAL CO.,INC. 【J-GAAP】

Earnings Report

HISAMITSU PHARMACEUTICAL CO.,INC. <4530> [TSE-P] announced its financial results after the market closed on October 10th (15:00). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending February 2025 (March to August) decreased by 7.3% from the same period last year to 10.7 billion yen. However, The progress rate against the 18.9 billion yen full-year plan was 57.1%, also surpassing the five-year average of 51.4%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the September to February period (second half) is expected to grow by 1.3% from the same period last year, reaching 8.11 billion yen.

In the most recent three-month period, from June to August (2Q), the consolidated ordinary profit decreased to 5.22 billion yen, a 11.8% decrease compared to the same period last year. However, the operating profit margin rose from 11.6% in the same period last year to 12.3%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Mar - Aug, 2022	59,619	4,913	8,870	6,504	81.6	55.3	Oct 12, 2022	J-GAAP
Mar - Aug, 2023	66,977	8,396	11,640	8,417	108.3	59.2	Oct 6, 2023	J-GAAP
Mar - Aug, 2024	75,456	9,006	10,788	9,098	122.7	57.1	Oct 10, 2024	J-GAAP
YoY	+12.7%	+7.3%	-7.3%	+8.1%	+13.3%

First Half Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar - Aug, 2024 Guidance	ー	ー	ー	ー	－	45	Apr 11, 2024	J-GAAP
Mar - Aug, 2024 Results	75,456	9,006	10,788	9,098	122.7	45	Oct 10, 2024	J-GAAP
Revision Rate	－	－	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Sep - Feb, 2023	74,729	4,771	8,009	5,552	72.2	42.50	Apr 11, 2024	J-GAAP
Sep - Feb, 2024 Guidance	76,544	5,494	8,112	6,702	91.4	45	Oct 10, 2024	J-GAAP
YoY	+2.4%	+15.2%	+1.3%	+20.7%	+26.6%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Feb, 2023	128,330	11,599	16,051	11,742	148.0	84.50	Apr 13, 2023	J-GAAP
Feb, 2024	141,706	13,167	19,649	13,969	181.6	85	Apr 11, 2024	J-GAAP
Feb, 2025 Guidance	152,000	14,500	18,900	15,800	215.4	90	Apr 11, 2024	J-GAAP
YoY	+7.3%	+10.1%	-3.8%	+13.1%	+18.6%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jun - Aug, 2023	34,881	4,035	5,927	4,368	56.2	11.6	Oct 6, 2023	J-GAAP
Sep - Nov, 2023	35,850	3,874	5,021	3,693	47.8	10.8	Jan 11, 2024	J-GAAP
Dec - Feb, 2023	38,879	897	2,988	1,859	24.2	2.3	Apr 11, 2024	J-GAAP
Mar - May, 2024	35,810	4,149	5,562	4,788	63.9	11.6	Jul 11, 2024	J-GAAP
Jun - Aug, 2024	39,646	4,857	5,226	4,310	58.1	12.3	Oct 10, 2024	J-GAAP
YoY	+13.7%	+20.4%	-11.8%	-1.3%	+3.4%